These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 19384840

  • 21. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G.
    J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
    [Abstract] [Full Text] [Related]

  • 22. Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation.
    Kanno Y, Okada H, Yamaji Y, Nakazato Y, Suzuki H.
    QJM; 2005 Mar; 98(3):199-203. PubMed ID: 15728401
    [Abstract] [Full Text] [Related]

  • 23. [Clinical evaluation of tonsillectomy with modified high-dose intravenous methylprednisolone therapy in patients with IgA nephropathy].
    Sugawara K, Takeda K, Nakai K, Takahashi N, Adachi T, Fukuda T, Miura S.
    Nihon Jinzo Gakkai Shi; 2008 Mar; 50(8):1017-23. PubMed ID: 19172803
    [Abstract] [Full Text] [Related]

  • 24. Effect of olmesartan on oxidative stress in hemodialysis patients.
    Kadowaki D, Anraku M, Tasaki Y, Kitamura K, Wakamatsu S, Tomita K, Gebicki JM, Maruyama T, Otagiri M.
    Hypertens Res; 2007 May; 30(5):395-402. PubMed ID: 17587751
    [Abstract] [Full Text] [Related]

  • 25. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.
    Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linné T.
    J Am Soc Nephrol; 2007 Jun; 18(6):1880-8. PubMed ID: 17513327
    [Abstract] [Full Text] [Related]

  • 26. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
    Manno C, Gesualdo L, D'Altri C, Rossini M, Grandaliano G, Schena FP.
    J Nephrol; 2001 Jun; 14(4):248-52. PubMed ID: 11506246
    [Abstract] [Full Text] [Related]

  • 27. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
    Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
    [Abstract] [Full Text] [Related]

  • 28. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy.
    Russo D, Pisani A, Balletta MM, De Nicola L, Savino FA, Andreucci M, Minutolo R.
    Am J Kidney Dis; 1999 May; 33(5):851-6. PubMed ID: 10213639
    [Abstract] [Full Text] [Related]

  • 29. Urinary angiotensin-converting enzyme 2 increases in diabetic nephropathy by angiotensin II type 1 receptor blocker olmesartan.
    Abe M, Oikawa O, Okada K, Soma M.
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):159-64. PubMed ID: 25287898
    [Abstract] [Full Text] [Related]

  • 30. Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy.
    Horita Y, Tadokoro M, Taura K, Suyama N, Taguchi T, Miyazaki M, Kohno S.
    Hypertens Res; 2004 Dec; 27(12):963-70. PubMed ID: 15894837
    [Abstract] [Full Text] [Related]

  • 31. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study.
    Maschio G, Cagnoli L, Claroni F, Fusaroli M, Rugiu C, Sanna G, Sasdelli M, Zuccalà A, Zucchelli P.
    Nephrol Dial Transplant; 1994 Dec; 9(3):265-9. PubMed ID: 8052432
    [Abstract] [Full Text] [Related]

  • 32. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
    Ozturk S, Sar F, Bengi-Bozkurt O, Kazancioglu R.
    Kidney Blood Press Res; 2009 Dec; 32(4):268-75. PubMed ID: 19776644
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial.
    Jo YI, Na HY, Moon JY, Han SW, Yang DH, Lee SH, Park HC, Choi HY, Lim SD, Kie JH, Lee YK, Shin SK.
    Korean J Intern Med; 2016 Mar; 31(2):335-43. PubMed ID: 26874511
    [Abstract] [Full Text] [Related]

  • 35. Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation.
    Sugihara M, Miura S, Takamiya Y, Kiya Y, Arimura T, Iwata A, Kawamura A, Nishikawa H, Uehara Y, Saku K.
    Hypertens Res; 2009 Jul; 32(7):625-30. PubMed ID: 19461652
    [Abstract] [Full Text] [Related]

  • 36. Treatment of hypertension with olmesartan medoxomil, alone and in combination with a diuretic: an update.
    Chrysant SG, Dimas B, Shiraz M.
    J Hum Hypertens; 2007 Sep; 21(9):699-708. PubMed ID: 17554345
    [Abstract] [Full Text] [Related]

  • 37. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Cheng G, Liu D, Margetts P, Liu L, Zhao Z, Liu Z, Tang L, Fang Y, Li H, Guo Y, Chen F, Liu F.
    Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy.
    Buemi M, Allegra A, Corica F, Aloisi C, Giacobbe M, Pettinato G, Corsonello A, Senatore M, Frisina N.
    Clin Pharmacol Ther; 2000 Apr; 67(4):427-31. PubMed ID: 10801253
    [Abstract] [Full Text] [Related]

  • 40. Effects of valsartan on the progression of chronic renal insufficiency in patients with nondiabetic renal diseases.
    Ishimitsu T, Kameda T, Akashiba A, Takahashi T, Ando N, Ohta S, Yoshii M, Inada H, Tsukada K, Minami J, Ono H, Matsuoka H.
    Hypertens Res; 2005 Nov; 28(11):865-70. PubMed ID: 16555574
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.